Postmenopausal Bleeding Clinical Trial
Official title:
The Accuracy of Three-dimensional Power Doppler Ultrasound in the Diagnosis of Endometrial Lesions in Patients With Postmenopausal Bleeding Compared With the Endometrial Histopathology.
100 women suffering post-menopausal bleeding will be included in the study. All the
participants will undergo 3D Transvaginal Ultrasound to assess the endometrium and myometrium
(for the presence of any focal lesions e.g. polypi) followed by 3D Power Doppler ultrasound
assessment of the vascular indices: vascularization index (VI), flow index (FI) and
vascularization-flow index (VFI) and endometrial volumes.
The results of the ultrasound and Doppler indices will be correlated to the histopathological
examination of specimens collected following fractional curettage or hysterectomy.
100 women suffering post-menopausal bleeding (occurred after at least 12 months of
amenorrhea) will be included in the study.
After obtaining an informed consent entailing the explanation of the study and its aim, all
participants will undergo the following; full history taking (including full menstrual
history and the date of menopause), complete physical examination, laboratory investigations
(complete blood count, liver function tests, kidney function tests and a coagulation
profile). Baseline 2D transvaginal ultrasound will be done to measure endometrial thickness
and to detect presence of any endometrial and myometrial focal lesions. 3D-transvaginal
ultrasonography will be done to acquire multi-planner view of the uterine cavity and detect
presence or absence of any cavitary or myometrial lesions and acquire endometrial volumes.
This will be followed by 3D Power Doppler Ultrasound assessment of the vascular indices
namely; vascularization index (VI), flow index (FI) and vascularization-flow index (VFI).
Transvaginal sonography will be performed for all patients using Voluson 730 PRO V
transvaginal volumetric probe transducer with frequency range of 5-8 MHz equipped with color,
power and pulsed Doppler capabilities. First, conventional gray-scale sonography will be
performed to obtain longitudinal and transverse sections of the uterus. Maximum endometrial
thickness (double-layer) will be measured in the longitudinal plane with the detection of any
focal lesions.
For Three-Dimensional Ultrasound: Once the B - mode had been completed, three-dimensional
images will be recorded. The volumes will be generated by the automatic rotation of the
mechanical transducer 360 degrees. The probe will be kept steady, the patient will be asked
to hold breath and volume mode will be switched on. With the use of the medium line density,
the typical acquisition time will be between 4 and 10 seconds. Visualization of the
endometrium in the three planes will be done to detect endometrial cavity. Endometrial
margin, echogenicity and presence of intrauterine fluid will be examined to notice the
presence of any heterogenic pattern, irregularity, asymmetry in the margin or local
thickening denoting the presence of polyp, endometrial hyperplasia, or carcinoma. The
myometrium will be also examined in the three planes to detect any other focal lesion e.g.
Fibroid or Adenomyosis.
For Power Doppler Study, the power Doppler gate will be activated for blood flow mapping of
the endometrium and endometrial-myometrial interface (sub-endometrial area). Power Doppler
settings will be set to achieve maximum sensitivity for detecting low velocity flow without
noise. Once the vessels have been identified, the pulsed Doppler sample volume will be
activated to obtain a flow velocity waveform (FVW). Vascularization index (VI), flow index
(FI) and vascularization-flow index (VFI) will be automatically calculated from three
consecutive FVWs. Only endometrial and endometrial-myometrial interface vessels were
included.
The patient will then be admitted for either a D and C operation (Endometrial curettage) or
for Total Abdominal Hysterectomy. All removed tissues will be sent for histopathological
examination of the endometrium or of any pathological uterine lesion. Pathological
examination results will be correlated to ultrasound (2D and 3D) and Doppler findings,
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05378152 -
Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity
|
N/A | |
Recruiting |
NCT04500496 -
Vaginal Dinoprostone Versus Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy
|
N/A | |
Not yet recruiting |
NCT06004908 -
Role of MRI in Diagnosis of Postmenopausal Bleeding Causes
|
||
Completed |
NCT00339651 -
Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
|
||
Completed |
NCT01076621 -
Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months
|
N/A | |
Completed |
NCT03330015 -
Patient's Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal Bleeding
|
N/A | |
Completed |
NCT03558321 -
Relation Between Human Epididymis Protein 4 (HE4) and Endometrial Pathology in Patients With Postmenopausal Bleeding
|
N/A | |
Completed |
NCT02488798 -
Office Hysteroscopy and 3D Power Doppler Vaginal Ultrasound in Assessment of Postmenopausal Bleeding
|
N/A | |
Active, not recruiting |
NCT06293066 -
Performance of Ultrasound in Women With Postmenopausal or Abnormal Uterine Bleeding Between White and Black Ethnic Groups- a Retrospective Cohort Study.
|
||
Recruiting |
NCT02822885 -
Uterine Artery and Spiral Artery Doppler Parameters in Patients With Postmenopausal Bleeding
|
N/A | |
Completed |
NCT03404154 -
Vocal in Assessment of Endometrium in Postmenopause
|
||
Not yet recruiting |
NCT03847415 -
Endometrial Evaluation in Cases of Postmenopausal Bleeding
|
||
Recruiting |
NCT03382145 -
A Review on the Outcome of Patient Managed in Postmenopausal Bleeding Clinic
|
||
Recruiting |
NCT03841916 -
Relation Between Body Mass Index and Endometrial Thickness
|